Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis

Journal of Intellectual Disability Research

Volumn 49, Issue 1, 2005, Pages 25-32

  Bäckman, Maria L ^a,b   Santavuori, P R ^a   Aberg L E ^a   Aronen, E T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE   (Finland)

Author keywords

JNCL; Neurological disorder; Psychiatric symptoms

Indexed keywords

ANTICONVULSIVE AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; CITALOPRAM; LEVOMEPROMAZINE; MELPERONE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE;

ADOLESCENT; ADULT; AGGRESSIVENESS; ARTICLE; ATTENTION; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MENTAL DISEASE; METHODOLOGY; NEURONAL CEROID LIPOFUSCINOSIS; PARENT; PATIENT MONITORING; PSYCHOSOMATIC DISORDER; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; SIDE EFFECT; SOCIOPATHY; STANDARDIZATION; SYMPTOMATOLOGY; TEACHER; THOUGHT DISORDER; TREATMENT PLANNING;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NEURONAL CEROID-LIPOFUSCINOSES; OBSERVER VARIATION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 13844266218     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2788.2005.00659.x     Document Type: Article

References (25)

1. Åberg L. E., Bäckman M., Kirveskari E. & Santavuori P. (2000) Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis. Epilepsia 41, 1296-302.
2. Åberg L. E., Tiitinen A., Aulti T. H., Kivisaari L. & Santavuori P. (2002) Hyperandrogenism in girls with juvenile neuronal ceroid lipofuscinosis. European Journal of Paediatric Neurology 6, 199-205.
3. Achenbach T. M. (1991) Integrative Guide for the 1991 CBCL/4-18, YSR and TRF Profiles. Department of Psychiatry, University of Vermont, Burlington.
4. Aronen E. T., Paavonen E. J., Fjallberg M., Soininen M. & Torronen J. (2000) Sleep and psychiatric symptoms in school-age children. Journal of the American Academy of Child and Adolescent Psychiatry 39, 502-8.
5. Bäckman M. L., Åberg L. E., Aronen E. T. & Santavuori P. R. (2001) New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses - a pilot study. European Journal of Paediatric Neurology 5 (Suppl. A), 163-6.
6. Bax M. C. O. & Colville G. A. (1995) Behaviour in mucopolysaccharide disorders. Archives of Disease in Childhood 73, 77-81.
7. Besag F. M. C. (1998) Lamotrigine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research 42 (Suppl. 1), 50-6.
8. Boustany R.-M. (1992) Neurology of the neuronal ceroid-lipofuscinoses: late infantile and juvenile types. American Journal of Medical Genetics 42, 533-5.
9. Boustany R.-M. & Filipek P. (1993) Seizures, depression and dementia in teenagers with Batten disease. Journal of Inherited Metabolic Diseases 16, 252-5.
10. 3) maps to human chromosome 16. Genomics 8, 387-90.
11. Hofman I. L. (1990) The Batten-Spielmeyer-Vogt Disease. Bartiméus Foundation, The Netherlands.
12. 3, juvenile NCL. In: The Neuronal Ceroid Lipofuscinoses (Batten Disease) (eds H. H. Goebel et al.), pp. 55-76. IOS Press, Amsterdam.
13. Järvelä I., Mitchison H. M., Munroe P. B., O'Rawe A. M., Mole S. E. & Syvänen A. -C. (1996) Rapid diagnostic test for the major mutation underlying Batten disease. Journal of Medical Genetics 33, 1041-2.
14. Johnston M. V. (2000) Commentary: potential neurobiologic mechanisms through which metabolic disorders could relate to autism. Journal of Autism and Developmental Disorders 30, 471-3.
15. Kohlscutter A., Laabs R. & Albani M. (1988) Juvenile neuronal ceroid lipofuscinosis (JNCL): quantitative description of its clinical variability. Acta Paediatrica Scandinavica 77, 867-72.
16. Kovacs M. (1981) Rating scales to assess depression in school-age children. Acta Paedopsychiatrica 46, 305-15.
17. Kovacs M. (1985) The children's depression inventory (CDI). Psychopharmacology Bulletin 21, 995-8.
18. Lamminranta S., Åberg L. E., Aulti T., Moren R., Laine T., Kaukoranta J. & Santavuori P. (2001) Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis. Journal of Intellectual Disability Research 45, 8-17.
19. Lou H. C. & Kristensen K. (1973) A clinical and psychological investigation into juvenile amaurotic idiocy in Denmark. Developmental Medicine and Child Neurology 15, 313-23.
20. Mole S. E. (1999) Batten's disease: eight genes and still counting. Lancet 354, 443-4.
21. Palmer D. N., Fearnley I. M., Walker J. E., Hall N. A., Lake B. D., Wolfe L. S., Haltia M., Martinus R. D. & Jolly R. D. (1992) Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). American Journal of Medical Genetics 42, 561-7.
22. Santavuori P. (1988) Neuronal ceroid lipofuscinoses in childhood. Brain Development 10, 80-3.
23. Santavuori P., Linnankivi T., Jaeken J., Vanhanen S.-L., Telakivi T. & Heiskala H. (1993) Psychological symptoms and sleep disturbances in neuronal ceroid-lipofuscinoses. Journal of Inherited Metabolic Diseases 16, 245-8.
24. Sorensen J. B. & Parnas J. (1979) A clinical study of 44 patients with juvenile amaurotic family idiocy. Acta Psychiatrica Scandinavica 59, 449-61.
25. Sourander A. & Piha J. (1997) Parent, teacher, and clinical ratings on admission to child psychiatric inpatient treatment: a study of cross-informant correlations using the CBCL, Rutter scales, and the CGAS. Nordic Journal of Psychiatry 51, 365-70.